Transcripts

BioNTech (BNTX) earnings call transcripts

Every BioNTech SE earnings call Gloomberb has transcribed, with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed 2026 as a transition toward a scaled, multi-product oncology company despite weaker COVID demand and delayed clinical milestones.

    Aug 04, 2026Positive0.55